Results 171 to 180 of about 648,282 (342)

Cortical morphology predicts placebo response in multiple sclerosis. [PDF]

Sci Rep, 2022
Cherkasova MV, Fu JF, Jarrett M, Johnson P, Abel S, Tam R, Rauscher A, Sossi V, Kolind S, Li DKB, Sadovnick AD, Machan L, Girard JM, Emond F, Vosoughi R, Traboulsee A, Stoessl AJ.   +16 more
europepmc   +1 more source

A response to ‘Acupuncture compared to placebo‐acupuncture for postoperative nausea and vomiting prophylaxis: A randomised placebo‐controlled patient and observer blind trial’, Streitberger K, Diefenbacher M, Bauer A et al . Anaesthesia 2004; 59: 142–9 [PDF]

, 2004
H. Lee
openalex   +1 more source

Mucosal‐Associated Invariant T Cells in Rheumatic Diseases

Arthritis &Rheumatology, EarlyView.
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor and restriction by the major histocompatibility complex class I–related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines.
Manon Lesturgie‐Talarek, Virginie Gonzalez, Lucie Beaudoin, Noémie Sénot, Corinne Miceli‐Richard, Yannick Allanore, Agnès Lehuen, Jerôme Avouac   +7 more
wiley   +1 more source

The Impact of Baseline Anxiety on Drug Placebo Separation and Drug/Placebo Response in an Acute Schizophrenia Clinical Trial-A Post-hoc Analysis. [PDF]

Schizophr Bull Open, 2023
Kott A, Brannan S, Wang X, Daniel D.
europepmc   +1 more source

Author response for "The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double‐blind, randomized, placebo‐controlled, clinical trial"

, 2021
Rahim Badrfam, Seyed‐Ali Mostafavi, Ali Khaleghi, Shahin Akhondzadeh, Atefeh Zandifar, Malihe Farid, Nami Mohammadian Khonsari, Mohammad Reza Mohammadi   +7 more
openalex   +1 more source

Erratum: Bosch-Sierra, N., et al. Effect of Fibre-Enriched Orange Juice on Postprandial Glycaemic Response and Satiety in Healthy Individuals: An Acute, Randomised, Placebo-Controlled, Double-Blind, Crossover Study. Nutrients 2019, 11, 3014 [PDF]

, 2021
Neus Bosch‐Sierra, Roger Marqués-Cardete, Aránzazu Gurrea-Martínez, Carmen Grau-del Valle, Clara Talens, Saioa Álvarez‐Sabatel, Carlos Bald, Carlos Morillas, Antonio Hernández‐Mijares, Celia Bañuls   +9 more
openalex   +1 more source

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

A comparative study of melatonin with placebo in attenuation of hemodynamic responses to Laryngoscopy and intubation [PDF]

Preeti Jamwal, Zulfiqar Ali, Mohinder Singh Chib, Deepika Jamwal, Iqra Nazir, Abdul Qayoom Lone, Sajad Aarif   +6 more
openalex   +1 more source

Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial [PDF]

, 2013
Kimmie Ng, Jamil B. Scott, Bettina F. Drake, Andrew T. Chan, Bruce W. Hollis, Paulette D. Chandler, Gary G. Bennett, Edward L. Giovannucci, Elizabeth Gonzalez-Suarez, Jeffrey A. Meyerhardt, Karen M. Emmons, Charles S. Fuchs   +11 more
openalex   +1 more source

Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis–Associated Interstitial Lung Disease: An Emulated Target Trial

Arthritis &Rheumatology, EarlyView.
Objective The optimal treatment strategy for rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) remains uncertain, and direct comparative data between biologics are limited. This study aimed to evaluate the effectiveness and safety of abatacept compared with rituximab in patients with RA‐ILD.
Po‐Cheng Shih, Shiow‐Ing Wang, Qing‐Wen Wang, James Cheng Chung Wei   +3 more
wiley   +1 more source